Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 309

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Open access
Grivas, P., Khaki, A.R., Wise-Draper, T.M., French, B., Hennessy, C., Hsu, C.-Y., Shyr, Y., Li, X., Choueiri, T.K., Painter, C.A., Peters, S., Rini, B.I., Thompson, M.A., Mishra, S., Rivera, D.R., Acoba, J.D., Abidi, M.Z., Bakouny, Z., Bashir, B., Bekaii-Saab, T., Berg, S., Bernicker, E.H., Bilen, M.A., Bindal, P., Bishnoi, R., Bouganim, N., Bowles, D.W., Cabal, A., Caimi, P.F., Chism, D.D., Crowell, J., Curran, C., Desai, A., Dixon, B., Doroshow, D.B., Durbin, E.B., Elkrief, A., Farmakiotis, D., Fazio, A., Fecher, L.A., Flora, D.B., Friese, C.R., Fu, J., Gadgeel, S.M., Galsky, M.D., Gill, D.M., Glover, M.J., Goyal, S., Grover, P., Gulati, S., Gupta, S., Halabi, S., Halfdanarson, T.R., Halmos, B., Hausrath, D.J., Hawley, J.E., Hsu, E., Huynh-Le, M., Hwang, C., Jani, C., Jayaraj, A., Johnson, D.B., Kasi, A., Khan, H., Koshkin, V.S., Kuderer, N.M., Kwon, D.H., Lammers, P.E., Li, A., Loaiza-Bonilla, A., Low, C.A., Lustberg, M.B., Lyman, G.H., McKay, R.R., McNair, C., Menon, H., Mesa, R.A., Mico, V., Mundt, D., Nagaraj, G., Nakasone, E.S., Nakayama, J., Nizam, A., Nock, N.L., Park, C., Patel, J.M., Patel, K.G., Peddi, P., Pennell, N.A., Piper-Vallillo, A.J., Puc, M., Ravindranathan, D., Reeves, M.E., Reuben, D.Y., Rosenstein, L., Rosovsky, R.P., Rubinstein, S.M., Salazar, M., Schmidt, A.L., Schwartz, G.K., Shah, M.R., Shah, S.A., Shah, C., Shaya, J.A., Singh, S.R.K., Smits, M., Stockerl-Goldstein, K.E., Stover, D.G., Streckfuss, M., Subbiah, S., Tachiki, L., Tadesse, E., Thakkar, A., Tucker, M.D., Verma, A.K., Vinh, D.C., Weiss, M., Wu, J.T., Wulff-Burchfield, E., Xie, Z., Yu, P.P., Zhang, T., Zhou, A.Y., Zhu, H., Zubiri, L., Shah, D.P., Warner, J.L., Lopes, GdL.·2021·Annals of Oncology

Abstract

BACKGROUND: Patients with cancer may be at high risk of adverse outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of patients with cancer and coronavirus 2019 (COVID-19) reported to the COVID-19 and Cancer Consortium (CCC19) to identify prognostic clinical factors, including laboratory measurements and anticancer therapies. PATIENTS AND METHODS: Patients with active or historical cancer and a laboratory-confirmed SARS-CoV-2 diagnosis recorded between 17 March and 18 November 2020 were included. The primary outcome was COVID-19 severity measured on an ordinal scale (uncomplicated, hospitalized, admitted to intensive care unit, mechanically ventilated, died within 30 days). Multivariable regression models included demographics, cancer status, anticancer therapy and timing, COVID-19-directed therapies, and laboratory measurements (among hospitalized patients). RESULTS: A total of 4966 patients were included (median age 66 years, 51% female, 50% non-Hispanic white); 2872 (58%) were hospitalized and 695 (14%) died; 61% had cancer that was present, diagnosed, or treated within the year prior to COVID-19 diagnosis. Older age, male sex, obesity, cardiovascular and pulmonary comorbidities, renal disease, diabetes mellitus, non-Hispanic black race, Hispanic ethnicity, worse Eastern Cooperative Oncology Group performance status, recent cytotoxic chemotherapy, and hematologic malignancy were associated with higher COVID-19 severity. Among hospitalized patients, low or high absolute lymphocyte count; high absolute neutrophil count; low platelet count; abnormal creatinine; troponin; lactate dehydrogenase; and C-reactive protein were associated with higher COVID-19 severity. Patients diagnosed early in the COVID-19 pandemic (January-April 2020) had worse outcomes than those diagnosed later. Specific anticancer therapies (e.g. R-CHOP, platinum combined with etoposide, and DNA methyltransferase inhibitors) were associated with high 30-day all-cause mortality. CONCLUSIONS: Clinical factors (e.g. older age, hematological malignancy, recent chemotherapy) and laboratory measurements were associated with poor outcomes among patients with cancer and COVID-19. Although further studies are needed, caution may be required in utilizing particular anticancer therapies. CLINICAL TRIAL IDENTIFIER: NCT04354701.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.annonc.2021.02.024

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 309

Metadata

Authors
Grivas, P., Khaki, A. R., Wise-Draper, T. M., French, B., Hennessy, C., Hsu, C.-Y., Shyr, Y., Li, X., Choueiri, T. K., Painter, C. A., Peters, S., Rini, B. I., Thompson, M. A., Mishra, S., Rivera, D. R., Acoba, J. D., Abidi, M. Z., Bakouny, Z., Bashir, B., Bekaii-Saab, T., Berg, S., Bernicker, E. H., Bilen, M. A., Bindal, P., Bishnoi, R., Bouganim, N., Bowles, D. W., Cabal, A., Caimi, P. F., Chism, D. D., Crowell, J., Curran, C., Desai, A., Dixon, B., Doroshow, D. B., Durbin, E. B., Elkrief, A., Farmakiotis, D., Fazio, A., Fecher, L. A., Flora, D. B., Friese, C. R., Fu, J., Gadgeel, S. M., Galsky, M. D., Gill, D. M., Glover, M. J., Goyal, S., Grover, P., Gulati, S., Gupta, S., Halabi, S., Halfdanarson, T. R., Halmos, B., Hausrath, D. J., Hawley, J. E., Hsu, E., Huynh-Le, M., Hwang, C., Jani, C., Jayaraj, A., Johnson, D. B., Kasi, A., Khan, H., Koshkin, V. S., Kuderer, N. M., Kwon, D. H., Lammers, P. E., Li, A., Loaiza-Bonilla, A., Low, C. A., Lustberg, M. B., Lyman, G. H., McKay, R. R., McNair, C., Menon, H., Mesa, R. A., Mico, V., Mundt, D., Nagaraj, G., Nakasone, E. S., Nakayama, J., Nizam, A., Nock, N. L., Park, C., Patel, J. M., Patel, K. G., Peddi, P., Pennell, N. A., Piper-Vallillo, A. J., Puc, M., Ravindranathan, D., Reeves, M. E., Reuben, D. Y., Rosenstein, L., Rosovsky, R. P., Rubinstein, S. M., Salazar, M., Schmidt, A. L., Schwartz, G. K., Shah, M. R., Shah, S. A., Shah, C., Shaya, J. A., Singh, S. R. K., Smits, M., Stockerl-Goldstein, K. E., Stover, D. G., Streckfuss, M., Subbiah, S., Tachiki, L., Tadesse, E., Thakkar, A., Tucker, M. D., Verma, A. K., Vinh, D. C., Weiss, M., Wu, J. T., Wulff-Burchfield, E., Xie, Z., Yu, P. P., Zhang, T., Zhou, A. Y., Zhu, H., Zubiri, L., Shah, D. P., Warner, J. L., & Lopes, G.
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2021-06
Volume
32
Issue
6
Pages
787-800
ISSN
0923-7534 (ISSN-L)
OpenAlex
W3136076419
Cited by
309
References
48
FWCI
22.75
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. https://app.cochat.ai/papers/10.1016/j.annonc.2021.02.024
The paper
Grivas, P., Khaki, A. R., Wise-Draper, T. M., French, B., Hennessy, C., Hsu, C.-Y., Shyr, Y., Li, X., Choueiri, T. K., Painter, C. A., Peters, S., Rini, B. I., Thompson, M. A., Mishra, S., Rivera, D. R., Acoba, J. D., Abidi, M. Z., Bakouny, Z., Bashir, B., . . . Lopes, G. (2021). Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. Annals of Oncology. https://doi.org/10.1016/j.annonc.2021.02.024

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.